Publication

Using BXD mouse strains in vision research: A systems genetics approach

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Eldon Geisert Jr, Emory UniversityRobert W. Williams, University of Tennessee
Language
  • English
Date
  • 2020-03-06
Publisher
  • MOLECULAR VISION
Publication Version
Copyright Statement
  • © 2020 Molecular Vision.
License
Title of Journal or Parent Work
Volume
  • 26
Start Page
  • 173
End Page
  • 187
Grant/Funding Information
  • This study was supported by an Unrestricted Grant from Research to Prevent Blindness, NEI grant R01EY017841 (E.E.G.), Owens Family Glaucoma Research Fund, P30EY06360 (Emory Vision Core) and DoD CDMRP Grant W81XWH-12-1-0255 from the USA Army Medical Research & Materiel Command and the Telemedicine and Advanced Technology (E.E.G.). GeneNetwork supported by NIGMS (R01GM123489), NIDA (P30DA044223) and the UT Center for Integrative and Translational Genomics, and funds from the UT-ORNL Governor’s Chair (R.W.W.).
Abstract
  • We illustrate the growing power of the BXD family of mice (recombinant inbred strains from a cross of C57BL/6J and DBA/2J mice) and companion bioinformatic tools to study complex genome-phenome relations related to glaucoma. Over the past 16 years, our group has integrated powerful murine resources and web-accessible tools to identify networks modulating visual system traits—from photoreceptors to the visual cortex. Recent studies focused on retinal ganglion cells and glaucoma risk factors, including intraocular pressure (IOP), central corneal thickness (CCT), and susceptibility of cellular stress. The BXD family was exploited to define key gene variants and then establish linkage to glaucoma in human cohorts. The power of this experimental approach to precision medicine is highlighted by recent studies that defined cadherin 11 (Cdh11) and a calcium channel (Cacna2d1) as genes modulating IOP, Pou6f2 as a genetic link between CCT and retinal ganglion cell (RGC) death, and Aldh7a1 as a gene that modulates the susceptibility of RGCs to death after elevated IOP. The role of three of these gene variants in glaucoma is discussed, along with the pathways activated in the disease process.
Author Notes
  • Eldon E. Geisert, Department of Ophthalmology, Emory University, Room B5512, 1365B Clifton Road N.E., Atlanta, GA, 30322; Phone: (404) 778 4239; FAX: (404) 778-2231; email: egeiser@emory.edu
Keywords
Research Categories
  • Chemistry, Biochemistry
  • Biology, Cell
  • Health Sciences, Opthamology
  • Biology, Genetics

Tools

Relations

In Collection:

Items